Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jerome

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Journal of Medicinal Chemistry|September 11, 1998
2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthaseT J Hagen, A A Bergmanis, S W Kramer, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2012
Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammationGraciela B Arhancet, Daniel P Walker, Sue Metz, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2013
Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: use of a conformation-based hypothesis to facilitate compound designDaniel P Walker, Graciela B Arhancet, Hwang-Fun Lu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)Chris P Carron, John I Trujillo, Kirk L Olson, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Journal of Medicinal Chemistry|September 11, 1998
2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthaseT J Hagen, A A Bergmanis, S W Kramer, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2012
Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammationGraciela B Arhancet, Daniel P Walker, Sue Metz, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2013
Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: use of a conformation-based hypothesis to facilitate compound designDaniel P Walker, Graciela B Arhancet, Hwang-Fun Lu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)Chris P Carron, John I Trujillo, Kirk L Olson, et al.
Pageof 9